Promakhos Therapeutics

Developer of immunotherapies for the treatment of inflammatory diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2020 groups3 employees language promakhos.com

Registered entities

Social engagement

Social engagement: 690 social following, 1 post in the last 12 months — above the industry median.

Investor mix

4 investors on record; lead investors include Y Combinator.

Investor typeCountShare
Venture capital250%
Accelerator & incubator125%
Other / undisclosed125%
Coming soon